Sort
11,323 grants matching “glioblastoma”
Project 2: Targeting metabolic vulnerabilities in glioblastoma
$334,315David A. Nathanson · University Of California Los Angeles · P50 · FY2019 · CA
Project 2: Targeting metabolic vulnerabilities in glioblastoma
$334,315David A. Nathanson · University Of California Los Angeles · P50 · FY2021 · CA
Defining cellular states of quiescence in human brain tumors
$334,304Patrick Paddison · Fred Hutchinson Cancer Center · R01 · FY2022 · NS
Vaso-occlusive Mechanisms that Induce Hypoxia and Cause Glioma Progression.
$334,267Daniel J Brat · Emory University · R01 · FY2008 · NS
Vaso-occlusive Mechanisms that Induce Hypoxia and Cause Glioma Progression.
$334,267Daniel J Brat · Emory University · R01 · FY2009 · NS
Vaso-occlusive Mechanisms that Induce Hypoxia and Cause Glioma Progression.
$334,267Daniel J Brat · Emory University · R01 · FY2007 · NS
Na-K-Cl cotransporter in Glioblastoma Multiforme
$334,260Dandan Sun · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · NS
Realizing the radiobiological impact of protons and high-LET particles in head and neck cancer and glioblastoma models
$334,259Jason Parsons · University Of Birmingham · R01 · FY2025 · CA
Targeting Tumorigenic Pathways in Glioblastoma with Oncolytic HSV
$334,191Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2013 · CA
Brain Endothelial TNF-R1 Can Function to Inhibit Angiogenesis
$334,173Candece L Gladson · Cleveland Clinic Lerner Com-Cwru · R01 · FY2013 · CA
PTP mu Supresses Brain Tumor Cell Migration and Dispersal
$334,168Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2010 · NS
Project 3: Using RNAi-based Spherical Nucleic Acid (SNA) Nanoconjugates Targeting Bcl2L12 to Promote Therapy-Induced Apoptosis in Glioblastoma
$334,161Alexander H. Stegh · Northwestern University At Chicago · P50 · FY2019 · CA
TWIST1 as a target for inhibition of glioma invasion
$334,117Robert C Rostomily · University Of Washington · R01 · FY2014 · CA
The Ureb-1 ubiquitin ligase in neural stem cells and cancer
$334,075Anna Lasorella · Columbia University Health Sciences · R01 · FY2010 · CA
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
$334,075Kenneth P Olive · Columbia University Health Sciences · R01 · FY2012 · CA
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
$334,075Kenneth P Olive · Columbia University Health Sciences · R01 · FY2011 · CA
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
$334,075Kenneth P Olive · Columbia University Health Sciences · R01 · FY2015 · CA
Contributions of Akt to Glioblastoma Formation
$334,028University Of California San Francisco · R01 · FY2002 · CA
Treatment of glioma with nanocombretastatin with MRI monitoring
$333,940Meser M. Ali · Henry Ford Health System · R01 · FY2019 · CA
Predicting the probabilistic complex invasive map of GBM cells
$333,877Orit Lavi · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Predicting the adaptation processes of GBM cells due to spatiotemporal stimuli
$333,877Orit Lavi · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
$333,876Michael D Gunn · Duke University · P01 · FY2018 · CA
IDO1 and Immunotolerance in Glioblastoma
$333,868Derek Alan Wainwright · Northwestern University At Chicago · R01 · FY2016 · NS
p85/p110 PI3 Kinase-Structure, function and Physiology
$333,828Jonathan M. Backer · Albert Einstein College Of Medicine · R01 · FY2013 · GM
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
$333,806Matthew L Meyerson · Dana-Farber Cancer Inst · R01 · FY2009 · CA